Analgesic Effect of Delta‐9‐Tetrahydrocannabinol

A preliminary trial of oral delta-9-tetrahydrocannabinol (THC) demonstrated an analgesic effect of the drug in patients experiencing cancer pain. Placebo and 5, 10, 15, and 20 mg THC were administered double blind to ten patients. Pain relief significantly superior to placebo was demonstrated at high dose levels (15 and 20 mg). At these levels, substantial sedation and mental clouding were reported.

[1]  D. W. Goodwin,et al.  Marijuana: CNS depressant of excitant? , 1974, The American journal of psychiatry.

[2]  B. Rodda,et al.  Dose‐response analysis of the efJects of tetrahydrocannabinol in man , 1971, Clinical pharmacology and therapeutics.

[3]  R. Mechoulam,et al.  A TOTAL SYNTHESIS OF DL-DELTA-1-TETRAHYDROCANNABINOL, THE ACTIVE CONSTITUENT OF HASHISH. , 1965, Journal of the American Chemical Society.

[4]  R. Mechoulam,et al.  Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish , 1964 .

[5]  K D KEELE,et al.  The pain chart. , 1948, Lancet.

[6]  W. Paton,et al.  The actions of cannabis in man , 1973 .